Lazard Ltd. (LAZ) Financials Nov 14, 2014, 4:28
Lazard Ltd. (LAZ) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Lazard Ltd.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.64B 2B 1.91B 2.01B 2.08B
Total Investment Income - - (7.74M) - -
Sundry Revenue/Income 89.17M 64.23M 76.36M 87.83M 90.41M
Trading Account Income - 0 (452,000) 22.33M 16.47M
Trust Income, Commissions & Fees 1.52B 1.92B 1.83B 1.9B 1.97B
Commission & Fee Income 1.52B 1.92B 1.83B 1.9B 1.97B
Total Expense 1.76B 1.67B 1.68B 1.89B 1.86B
Total Interest Expense 107.89M 97.71M 90.13M 81.57M 79.38M
Depreciation & Amortization Expense 27.53M 30.58M 36.5M 39.21M 44.86M
Other Operating Expense 247.52M 207.19M 192.77M 209.66M 252.1M
2009 2010 2011 2012 2013 5-year trend
Operating Income (119.68M) 330.76M 235.5M 123.89M 216.81M
Non-Operating Income (Expense) 0 0 0 0 0
Non-Operating Interest Income 0 0 0 0 0
Miscellaneous Non Operating Expense 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Unusual Expense 62.55M 87.11M 0 0 0
Pretax Income (182.23M) 243.65M 235.5M 123.89M 216.81M
Income Taxes 6.01M 49.23M 44.94M 31.1M 51.69M
Income Tax - Current - Domestic (5.64M) 13.49M 1.84M 7.91M (3.85M)
Income Tax - Current - Foreign 35.08M 27.63M 35.89M 27.65M 41.08M
Income Tax - Deferred - Domestic (19.29M) 2.79M 10.05M (3.33M) 18.97M
Income Tax - Deferred - Foreign (4.15M) 5.33M (2.83M) (1.13M) (4.52M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 - 0 0 0
Other After Tax Income (Expense) 0 0 284,000 7,000 0
Consolidated Net Income (188.25M) 194.42M 190.84M 92.79M 165.11M
Minority Interest Expense (58M) 19.44M 15.64M 8.48M 4.9M
Net Income (130.24M) 174.98M 175.2M 84.32M 160.21M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (130.24M) 174.98M 175.2M 84.32M 160.21M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (130.24M) 174.98M 175.2M 84.32M 160.21M
EPS (Basic) (1.66) 1.68 1.48 0.72 1.33
Basic Shares Outstanding 78.31M 104.41M 118.03M 116.95M 120.85M
EPS (Diluted) (1.66) 1.36 1.36 0.65 1.21
Diluted Shares Outstanding 78.31M 138.47M 137.63M 129.33M 133.74M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unpacking Small Cell Lung Cancer Progress These days, it feels like we're standing on the brink of something real big in the fight against small cell lung cancer. And I'm not talking about pie-in-the-sky ideas—there are some serious game changers coming down the pike, folks. You see, in the past, this aggressive cancer type was pretty much a death sentence. But thanks...
Continue Reading
Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...
Continue Reading
Shake-Up at Gildan: Investors Take Legal Action Gildan Activewear Inc. (NYSE:GIL) got themselves in hot water, folks. They've landed on the wrong side of an investor class action lawsuit after claims of shady business tactics sent their stock plummeting like a rock in June. We're talking about an 18.75% nosedive here. That's not just a slip—it's a fall worth wearing a...
Continue Reading
Bridging Borders to Tackle Disasters It seems like everyone and their grandma talks disaster aid, but when two giants like the US State Department's Bureau of Disaster and Humanitarian Response (DHR) and the Inter-American Institute for Cooperation on Agriculture (IICA) grab a coffee—real serious action is brewing. Why This Matters The partnership's not just talk. Let's...
Continue Reading
Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....
Continue Reading
Sinking Shares: The Webull Saga Unfolds Shady business practices can really make a stock take a nosedive, and that's what's happening with Webull Corporation, trading under NASDAQ:BULL. The alarm bells started ringing when the truth about their operations and ties to China came out. Turns out, what looked like a stable American fintech platform had its roots digging deep...
Continue Reading
Breaking New Ground with ReadyGrid If you've been keeping an eye on the energy storage landscape, today's a big day. Coulomb Solutions, Inc. (CSI) is shaking things up by spinning off ReadyGrid, its own dedicated mobile energy storage powerhouse. The move is designed to tackle the pressing power challenges that have been nagging industries across the board, from...
Continue Reading
Gaps in a Booming Industry Trading cards might sound like kid stuff, but don’t be fooled—there's billions riding on paper and ink these days. Yet, a dark cloud hovers over the trading card scene, where questions of transparency and accountability loom large. Digital repacks and those dicey randomized packs have folks questioning what’s in the mix: Is it a safe bet...
Continue Reading
Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...
Continue Reading
Lawsuit Clouds Hang Over Doximity The courtroom isn't typically where you find stocks making headlines, but Doximity's recent plunge isn't just a market hiccup. After a rough patch, an alleged misstep lands them squarely under the legal microscope, and investors have questions. Tracing Doximity's Rocky Financial Reports First, let's rewind to November last year. Doximity...
Continue Reading
Top 5 Most Recently Viewed Articles
Trump's Lavish Ballroom Project President Donald Trump is working on an extravagant project to create a $300 million ballroom within the White House. Reports suggest that he intends to name the new venue after himself, garnering both curiosity and intrigue. The President Donald J Trump Ballroom The Name in the Spotlight Inside the highest echelons of power, sources have...
Continue Reading
CommunityAmerica Credit Union Welcomes Kathy O’Neill as President CommunityAmerica Credit Union has appointed Kathy O’Neill, a seasoned expert in financial services, as the new President for its St. Louis region. With a wealth of experience in managing retail banking operations and fostering community engagement, O’Neill's appointment represents a crucial...
Continue Reading
Vaycaychella Announces Jason Armstrong as New CEO Vaycaychella, Inc. (NASDAQ: VAYK) has made headlines with the appointment of Jason Armstrong as its Chief Executive Officer. This decision comes as the company aims to enhance its focus on organic growth that targets revenues between $3 million to $5 million in the near future. Jason, who has been on the company's board...
Continue Reading
A Bold New Era for Olympic Sports The 2026 Winter Olympics? Huge deal! We're talking about a whole new vibe coming from Milan and Cortina d'Ampezzo. It's like the world's shifting gears from a stuck-up medal race to something way more meaningful—resilience and character! Dmitry Druzhinsky pops up as a key player in all this, and let’s face it, he’s not just some...
Continue Reading
Health Enterprise Partners Recognizes Dr. Patrick McGrath Patrick McGrath, PhD, Chief Clinical Officer of NOCD, honored for leadership and commitment to clinical innovation. Health Enterprise Partners (HEP) proudly announces today the recognition of Dr. Patrick McGrath, Chief Clinical Officer of NOCD, as the distinguished recipient of their second annual RISE Above Award....
Continue Reading